Weeding out the myths on Medical Cannabis
|
|
- Amber O’Brien’
- 5 years ago
- Views:
Transcription
1 Weeding out the myths on Medical Cannabis Presented by A/Prof David Allsop Lambert Initiative for Cannabinoid Therapeutics University of Sydney For Walk on the Wild Side 2016: Superstition or Evidence? Brisbane The University of Sydney Page 1
2 Medical Cannabis - The myths Myth # 1. Medical cannabis is illegal in Australia Myth # 2. All cannabis is good for you (Straw man) Myth # 3. The evidence for medical cannabis is in the studies have been done The University of Sydney Page 2
3 Myth # 1. Medical cannabis is illegal in Australia The University of Sydney Page 3
4 Prohibited Substance The University of Sydney Page 4
5 Cannabis hasn t always been illegal Pfizer 1929 (Parke-Davis) The University of Sydney Page 5
6 Cannabis prohibition The University of Sydney Page 6
7 Restrictions on the manufacture, movement and use of narcotic drugs cannabis (THC) = Schedule 9 The University of Sydney Page 7
8 Prohibited Substance The University of Sydney Page 8
9 Legal medical cannabis when separately specified in schedules Sativex (THC+CBD) is Schedule 8 Cannabidiol (CBD) is Schedule 4 Dronabinol and Nabilone (THC) Schedule 8 The University of Sydney Page 9
10 The University of Sydney Page 10
11 Special Access Scheme - TGA Specialist doctor applies to the TGA to import drugs on behalf of a patient The TGA s assessment balances a number of factors, including: (1)The patient s doctor must be able to justify using the product, demonstrating the seriousness of the patient s condition and the history of other treatments. (2) Information about the route of administration, dose, active ingredients, proposed monitoring procedures, and any data on the safety and efficacy of the product. (3) The prescriber must have the relevant expertise appropriate to the condition being treated. The University of Sydney Page 11
12 Special Access Scheme - TGA - State based laws have been at odds with TGA allowance of Schedule 9 drugs, but individual states, including QLD, have recently adapted to facilitate The University of Sydney Page 12
13 Any schedule of drug can be used in a clinical trial, including cannabis plant matter - Drug must meet minimum quality standards (e.g. GMP certified) - Drug and trial must be approved by an authorized ethics committee The University of Sydney Page 13
14 Pharmaceutical THC vs. vaporised botanical leaf cannabis for cachexia (wasting disorder) in palliative care (NSW government funded clinical trial) AIM: Vaporised high THC botanical leaf matter in stimulating appetite in a palliative care population. The University of Sydney Page 14
15 Now the federal government are making production and manufacture legal in Australia The University of Sydney Page 15
16 And the states are scrambling to bring their own laws into line 2017 onwards will see home grown cannabis medicines in Australia The University of Sydney Page 16
17 Finally, the TGA are in the process of moving cannabis out of the S9 poisons category, into S8 The University of Sydney Page 17
18 Myth # 1. Medical cannabis is illegal in Australia SORT OF! The University of Sydney Page 18
19 Myth #2. All Cannabis is good for you "God said, 'Behold, I have given you every herb bearing seed... And the earth brought forth grass and herb yielding seed after its kind. The University of Sydney Page 19
20 Myth #2. All Cannabis is good for you The University of Sydney Page 20
21 Last 12 month drug use ( ) National Drug Strategy Household Survey % Cannabis is consistently the most prevalent illicit drug used in Australia The University of Sydney Page 21
22 Number of treatment episodes 2008/2009 Report on the National Minimum Data Set Number of treatment episodes 2 nd most prevalent reason for presentations to AOD services in Australia The University of Sydney Page 22
23 Research $ for cannabis is bad The University of Sydney Page 23
24 Cannabis Harms New England Journal of Medicine 2014 The University of Sydney Page 24
25 High THC levels in Australian Street Cannabis Swift W, Wong A, Li KM, Arnold JC, et al. (2013) Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile. PLoS ONE 8(7): e doi: /journal.pone The University of Sydney Page 25
26 Cannabis Dependence ALL OTHER CANNABIS USERS 90% DEPENDENT 10%* *Hall, W., & Pacula, R.L. (2003). Cannabis use and dependence: Public health and public policy. Cambridge: Cambridge University Press. The University of Sydney Page 26
27 Profile of cannabis withdrawal The University of Sydney Page 27
28 Cannabinoid Replacement Therapy Inpatient cannabis withdrawal Allsop et al (2015) JAMA Psychiatry The University of Sydney Page 28
29 Suppression of Cannabis Withdrawal. The University of Sydney Page 29
30 The University of Sydney Page 30
31 Myth #2. All Cannabis is good for you "God said, 'Behold, I have given you every herb bearing seed... And the earth brought forth grass and herb yielding seed after its kind. The University of Sydney Page 31
32 Myth # 3. The evidence for medical cannabis is in the studies have been done The University of Sydney Page 32
33 The University of Sydney Page 33
34 Cannabinoids ever given in purified form to humans in scientific studies (estimate) Abbreviation Full name THC Δ9-Tetrahydrocannabinol THCA Δ9-Tetrahydrocannabinolic acid THCV Δ9-Tetrahydrocannabivarin THCVA Δ9-Tetrahydrocannabivarin acid CBD Cannabidiol CBDA Cannabidiolic acid CBDV Cannabidivarin CBDVA Cannabidivarin acid CBG Cannabigerol CBGA Cannabigerolic acid CBGV Cannabigerovarin CBGVA Cannabigerovarinic acid Abbreviation Full name CBC Cannabichromene CBCA Cannabichromenic acid CBCV Cannabichromevarin CBCVA Cannabichromevarinic acid CBN Cannabinol CBNA Cannabinolic acid CBNV Cannabinovarin CBNVA Cannabinovarin acid CBL Cannabicyclol CBLA Cannabicyclolic acid CBV Cannabivarin The University of Sydney Page 34
35 The University of Sydney Page 35
36 The University of Sydney Page 36
37 The University of Sydney Page 37
38 Quality of the evidence - Risk of bias? - Was it double blind, single blind, open label? - Was it randomised appropriately? - What was the sample size? - Was the main outcome measure specified clearly a priori? Or were findings fished for? - How many studies contribute to that evidence base? - Are there enough good quality studies to do a meta analysis The University of Sydney Page 38
39 State of the evidence The University of Sydney Page 39
40 State of the evidence - Whiting et al JAMA June 2015 Illness Reduction in Pain # of Studies # of patients Findings 28 (8) % on cannabis vs 31% on placebo Spasticity in MS reduction (on a 6 point scale) Nausea and Vomiting 28 (3)? OR 3.82 complete response Strength of Evidence Just significant; Moderate Just significant; Moderate Mixed results; Low Weight + in HIV THC > placebo Not significant; Low Depression 5 (0)? Cannabis = placebo Secondary outcomes; Low Anxiety 1 8 CBD > placebo Significant; Low Sleep disorders 2 54 THC > placebo Significant; Low Tourettes 2 36 THC > placebo Significant; Low Glaucoma 1 6 Cannabis = placebo Not significant; Low Psychosis 2 71 CBD = placebo & amisulpride Not significant; Low The University of Sydney Page 40
41 The University of Sydney Page 41
42 What about epilepsy? studies, total of 30 patients (8 in each), mixed results, very low quality evidence 2014 American Academy of Neurologists available evidence is insufficient to draw conclusions about the safety and efficacy of cannabinoids in the treatment of epilepsy The University of Sydney Page 42
43 What about epilepsy? The University of Sydney Page 43
44 Myth # 3. The evidence for medical cannabis is in the studies have been done The University of Sydney Page 44
45 Australia is stepping up to address the Cannabis Evidence Gap The University of Sydney Page 45
46 The Lambert Initiative for Cannabinoid Therapeutics Lambert Initiative University of Sydney NSW, Australia 2006 The University of Sydney Page 46
47 Major aim To explore the potential of and to develop novel cannabinoidbased therapies for the treatment of: Epilepsy Pain Cancer Dementia Mental illness/addictions Obesity/diabetes/metabolic disorders The University of Sydney Page 47
48 Areas of development -from farm to pharma- Sourcing and extracting cannabinoids Medicinal chemistry Cellular screens Preclinical animal models Early human (phase 1) trials Human psychopharmacology Larger clinical trials The University of Sydney Page 48
49 Unlocking the medicinal potential of the cannabis plant The University of Sydney Page 49
50 o o o Over 100 cannabinoids in the plant, many of which are non-psychoactive. Each cannabinoid has its own therapeutic potential This includes terpenoids, flavonoids, and ensemble and entourage effects The University of Sydney Page 50
51 Sourcing cannabinoids The University of Sydney Page 51
52 Cannabinoid sourcing Plant genetics R&D Extraction Ecofibre Ecofibre ihemp CBD CBDA CBDV CBDVA CBC CBCA CBN THCA THCV THCVA Biomedical R&D GMP production The University of Sydney Page 52
53 Preclinical research The University of Sydney Page 53
54 Preclinical vision (epilepsy example) *Phytocannabinoids Screening against epilepsy-relevant targets FLIPR (Connor) TEVC (Collins) Dynamin (Robinson) NIH Psychoactive Drug Screen Patch clamping electrophysiology *+ tweaked versions + combinations + terpenes Animal models that express epilepsy-relevant channelopathies Back translation The University of Sydney Page 54
55 Areas of development Sourcing and extracting cannabinoids Medicinal chemistry Cellular screens Preclinical animal models Early human (phase 1) trials Human psychopharmacology Larger clinical trials The University of Sydney Page 55
56 Areas of development Sourcing and extracting cannabinoids Medicinal chemistry Cellular screens Preclinical animal models Early human (phase 1) trials Human psychopharmacology Larger clinical trials The University of Sydney Page 56
57 Areas of development Sourcing and extracting cannabinoids Medicinal chemistry Cellular screens Preclinical animal models Early human (phase 1) trials Human psychopharmacology Larger clinical trials The University of Sydney Page 57
58 Cannabidivarin (CBDV) for paediatric epilepsy (NSW government funded clinical trial) AIM: To test the efficacy of CBDV in treating seizures in children with epilepsy. The University of Sydney Page 58 Team: I. McGregor, D. Allsop, N. Lintzeris, Sydney Children s Hospital Network, GW Pharmaceuticals
59 Randomised control trial using oral THC/CBD extract to treat chemotherapy induced nausea and vomiting (CINV) (NSW government funded clinical trial) AIM: To examine the safety and efficacy of orally administered THC/CBD extract as ancillary medication to standard treatment in CINV. The University of Sydney Page 59
60 Remain nimble in a shifting landscape Amendment to Narcotics Act 1964 Will enable licenses for cultivation and manufacture of cannabis for therapeutic use Rescheduling from Schedule 9 to 8 To overcome current laws that make all cannabis (even as a medicine) a prohibited substance State based legislative frameworks emerging to enable compassionate use Different approaches by different states but expect increased use in coming 1-4 years The University of Sydney Page 60
61 Medicinal cannabinoid use for childhood epilepsy in the Australian community PELICAN AIM: To document the types and patterns of cannabinoid use for the treatment of childhood epilepsy in Australia. Face-to-face semi-structured interview Collection of sample of cannabinoid product Chemical analysis of cannabinoid product The University of Sydney Page 61 Team: A. Suraev, N. Lintzeris, D. Allsop, J. Arnold, J. Stuart, I. McGregor.
62 The usual research cycle The University of Sydney Page 62
63 PELICAN The University of Sydney Page 63
Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationGuidance for the use of. medicinal cannabis. in Australia. Patient information
Guidance for the use of medicinal cannabis in Australia Patient information Version 1, December 2017 Copyright Commonwealth of Australia 2017 This work is copyright. You may reproduce the whole or part
More informationDetection of cannabinoids in Cannabis sativa plants
Detection of cannabinoids in Cannabis sativa plants THCA CBCA CBDA THC CBD CBC Thin Layer Chromatography (TLC) Agilent Cannabichromene,CBC Cannabigerol, CBG (-)-Δ9-Tetrahydrocannabinol,THC Δ9- tetrahydro-cannabivarol,
More informationMedicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer
Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance
More informationCannabis in the treatment of Autism:
Cannabis in the treatment of Autism: Are we ready? Deb Karhson, PhD and Lawrence Fung, MD, PhD Cannabis Anecdotal Data: Comparing Epilepsy and Autism+ Science of Cannabinoids: Endocannabinoid System Receptor
More informationAnalytical Reference Standards. High Quality Noramco-qualified Standards
Analytical Reference Standards High Quality Noramco-qualified Standards Highly characterized, highly purified standards The United States Food and Drug Administration requires reference-standard materials
More informationAnalytical Reference Standards. High Quality Noramco-qualified Standards
Analytical Reference Standards High Quality Noramco-qualified Standards Highly characterized, highly purified standards The United States Food and Drug Administration requires reference-standard materials
More informationSwissmedic Approval Options and Limits. Swiss Task Force for Cannabinoids in Medicine Conference November 12, 2016
Swissmedic Approval Options and Limits Swiss Task Force for Cannabinoids in Medicine Conference November 12, 2016 Cannabis Ordinance on the lists of narcotics, psychotropic substances, precursors and auxiliary
More informationMedical Marijuana: High Expectations Dr. Ally Dering-Anderson, RP University of Nebraska College of Pharmacy. Speaker Contact Information
Medical Marijuana: High Expectations Dr. Ally Dering-Anderson, RP University of Nebraska College of Pharmacy Speaker Contact Information Dr. Ally Dering-Anderson, RP Clinical Associate Professor of Pharmacy
More informationCannabis and cannabinoids for medicinal purposes
Cannabis and cannabinoids for medicinal purposes International Evidence and Evidence for Practice in Australia Michael Farrell Louisa Degenhardt, Wayne Hall, Nicholas Buckley, Megan Weir, Suzi Neilsen,
More informationPoisons Amendment (2018 Measures No. 1) Instrument 2018
Poisons Amendment (2018 Measures No. 1) Instrument 2018 I, {insert author} make the following instrument. Dated 1 st April 2018 {insert author} Poisons Amendment (2018 Measures No. 1) Instrument 2018 Page
More information(THC) Delta9-tetrahydrocannabinol:
(THC) Delta9-tetrahydrocannabinol: Most prominent compound found in the cannabis plant found in the 1960 s. THC binds to the CB1 and CB2 receptors causing a change in the function of the cell it is binding.
More informationOverview of the Emerging Cannabis Industry
Overview of the Emerging Cannabis Industry and AIHA s Cannabis Industry Health and Safety Task Force Rob Kleinerman, MPH, CIH Chair AIHA Cannabis Industry Health and Safety Task Force DISCLAIMER The American
More informationAustralian Medicinal Cannabis Pricing Analysis
Australian Medicinal Cannabis Pricing Analysis Q3 2018 cannabis access clinics » Entry level product prices fall by close to 50% over 12 months» Number of legal products available up threefold» Pharmacy
More informationAct 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
More informationHistory Of Medical Cannabis
History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction
More informationMedical Marijuana Consent Form
Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal
More informationDear Colleague SUPPLEMENTARY INFORMATION ON CANNABIS BASED PRODUCTS FOR MEDICINAL USE
Directorate of Chief Medical Officer T: 0131-244 2470 E: John.Hannah@gov.scot Dear Colleague SUPPLEMENTARY INFORMATION ON CANNABIS BASED PRODUCTS FOR MEDICINAL USE Following my letter of 31 October 2018
More informationSusan Audino, PhD S.A. Audino & Associates, LLC
Cachexia, Cancer, Chronic Pain, Epilepsy, Glaucoma, HIV, AIDS, Multiple Sclerosis, Nausea, ALS, Crohn s, Hepatitis C, Anorexia, Arthritis, Migraine, Parkinson s, Damage to the Nervous Tissue of the Spinal
More informationCannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology
Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology 2 Pamela C. Cartright, MAE, RT (R)(T) Assistant Professor and Program Director Radiation Therapy Program
More informationCannabinoids: access and symptom management in cancer
Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%
More informationThe Scientific Side of Medical Marijuana
The Scientific Side of Medical Marijuana Ken Mackie, MD Indiana University Bloomington, IN December 3, 2009 kmackie@indiana.edu Financial disclosures NIH (NIDA) - research grants Alzheimer s Association
More informationMOTION FOR A RESOLUTION
European Parliament 2014-2019 Committee on the Environment, Public Health and Food Safety 2.10.2018 2018/2775(RSP) MOTION FOR A RESOLUTION further to Question for Oral Answer B8-0000/2018 pursuant to Rule
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationGW Pharmaceuticals plc. Investor Presentation August 2014
GW Pharmaceuticals plc Investor Presentation August 2014 Forward Looking Statements and Disclaimer This presentation contains forward-looking statements. Some of the matters discussed concerning our operations
More informationQualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection
Application Note Cannabis Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection Authors Mike Adams, Annette Roth, Sue D
More informationADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP
ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP Page 1 1. In what year did the possession and transfer of cannabis for recreational use become illegal in the United States? A. 1937 B. 1941 C. 1933 2.
More informationCurious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD
Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests
More informationChanging the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 TITLE: Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol
More informationCannabis and the Endocannabinoid System
Cannabis and the Endocannabinoid System September 7, 2018 Bangkok, Thailand David Bearman, MD Goleta, California Executive VP, American Academy of Cannabinoid Medicine AACMSITE.org Shen Nung Ping
More informationWAREHOUSING AND DISTRIBUTION OF CANNABIS PRODUCTS. RACI Pharmaceutical Science Group (NSW) Supply and Use of Medicinal Cannabis
WAREHOUSING AND DISTRIBUTION OF CANNABIS PRODUCTS RACI Pharmaceutical Science Group (NSW) Supply and Use of Medicinal Cannabis 28 March 2017 Bruce Battye Director Pharmaceutical Regulatory Unit, NSW Health
More informationPHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS
Toll Free: 1.800.516.1504 info@vitaliset.com vitaliset.com Find us on Instagram! vitalisextractiontech PHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS A recent history of prejudice against the cannabis
More informationMedical vs Recreational Use of Cannabis. 11 th December 2017
1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.
More informationQuality Assessments for an Organically-Complex Drug - Part 1 Background and the Chemometrics Role
Quality Assessments for an Organically-Complex Drug - Part 1 Background and the Chemometrics Role Dr Peter Gibson Technical Director Sovereign House, Vision Park, Histon, Cambridge, CB24 9BZ Global leaders
More informationCannabis: Therapeutic properties of the plant
Cannabis: Therapeutic properties of the plant Medicinal cannabis is still illegal to be used in South Africa. In a victory for marijuana users across South Africa, ConCourt has officially legalised cannabis
More informationCannabis & Hemp therapeutic solutions
Cannabis & Hemp therapeutic solutions with Our Cannabis & Hemp quality standards Thanks to their rich characterization and proprietary extraction method, our therapeutic solutions are a reference point
More informationAnalytical Results SC Laboratories Oregon LLC ORELAP# 4133/OLCC# D SW 74th Ave Suite 110, Tigard, OR
Analytical s Sample Name: Tested for: Mistery Haze SoFresh Farms Compliance Testing - Flower Laboratory ID: 18A0026-03 Matrix: Useable Marijuana Sample Metrc ID: 1A4010300001E17000002017 Lot # RH R1 MH
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationMedical Marijuana. Navigating Medical Marijuana in Workers Compensation
Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationAnti-inflammatory Cannabinoids without psycho-active side-effects
Anti-inflammatory Cannabinoids without psycho-active side-effects Opportunities for further development to a drug formulation Introduction More than 5000 years ago, the Chinese already used Cannabis for
More informationMedical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.
Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound
More informationWELSH HEALTH CIRCULAR
WHC/2018/039 WELSH HEALTH CIRCULAR Issue Date: 30 October 2018 STATUS: INFORMATION CATEGORY: HEALTH PROFESSIONAL LETTER Title: The rescheduling of Cannabis for medicinal purposes Date of Expiry / Review
More informationThe Determination of CBD and General Cannabinoid Content in Hemp Oils Using HPLC with UV Detection
High Performance Liquid Chromatography No. HPLC-018 The Determination of CBD and General Cannabinoid Content in Hemp Oils Using HPLC with UV Detection Introduction Medical marijuana generally possesses
More informationCase 1:18-cv NYW Document 1-1 Filed 07/30/18 USDC Colorado Page 1 of 12 EXHIBIT A
Case 1:18-cv-01922-NYW Document 1-1 Filed 07/30/18 USDC Colorado Page 1 of 12 EXHIBIT A Case 1:18-cv-01922-NYW Document 1-1 Filed 07/30/18 USDC Colorado Page 2 of 12 I IIIII IIIIIIII Ill lllll lllll lllll
More informationSTAKEHOLDER CONSULTATION
STAKEHOLDER CONSULTATION DRAFT NSW CANNABIS MEDICINES PRESCRIBING GUIDANCE BACKGROUND Many Australians are now able to access cannabinoids for medicinal purposes under the supervision of a medical practitioner.
More informationJames McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada
James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into
More informationPotency Claims - only as Accurate as your Reference Material
Potency Claims - only as Accurate as your Reference Material Challenges with unstable TC and related Cannabinoids By Mitzi Rettinger Cerilliant Corporation Why is accuracy of potency assignment is important?
More informationCustomer Sample Type Method Technique
Sample ID 18A23000003 Cannabis Potency HPLC-UV Chemistry Cannabidivarin (CBD-V) 1.29 mg/dose Cannabidiol (CBD) 646.50 mg/dose Cannabigerol (CBG) Tetrahydrocannabivarin (THC-V) 24.7 mg/dose
More informationCannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017
Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:
More informationFederal Law: Marijuana
Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not
More informationCannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD
Cannabidiol as a potential treatment for anxiety disorders Esther Blessing, MD PhD Overview History and of cannabidiol (CBD) and cannabis Safety and tolerability of CBD CBD pharmacology Clinical need for
More informationThe Company. Beyond Pioneering
The Company Beyond Pioneering Standardisation Bedrocan is the world s most experienced producer of legal medicinal cannabis. We are currently the only company producing medicinal cannabis flos to good
More informationAMENDMENTS EN United in diversity EN. European Parliament
European Parliament 2014-2019 Committee on the Environment, Public Health and Food Safety 17.8.2018 2018/2775(RSP) AMDMTS 1-84 Dubravka Šuica, Guillaume Balas, Urszula Krupa, Catherine Bearder, Martin
More informationCannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system
Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 9 Infinity II/63B LC/TOF system Application Brief Authors Mike Adams, Karen Kaikaris, and A. Roth CWC Labs Joan Stevens, Sue D
More informationResearch on Cannabis and PD: Is there any evidence?
Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES
More informationExtraction, Isolation and Analysis of Cannabis Extract and Preparation
Extraction, Isolation and Analysis of Cannabis Extract and Preparation A S S O C.PROF. D R. N A R I SA K A M K AEN D I R EC TO R O F H E R BAL P H A R MACY C O L L EG E O F P H A R MACY, R A N G S I T
More informationWe will start momentarily at 2pm ET
We will start momentarily at 2pm ET Slides available now! Recordings will be available to ACS members after two weeks. http://acswebinars.org/cannabis Contact ACS Webinars at acswebinars@acs.org 1 Have
More informationMedical Cannabis and OMT
Medical Cannabis and OMT David R. Beatty, DO Professor of Osteopathic Principles and Practice, WVSOM November 4, 2017 Objectives At the completion of this presentation the attendee should be able to: 1.
More informationWHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts
More informationMarijuana as Medicine
Marijuana as Medicine What is medical marijuana? The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions.
More informationMedical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015
Medical Marijuana Kent W. Peterson, MD, FACOEM Occupational Health Strategies, Inc. Charlottesville, VA Speaker Disclosure Requirements 1. Do not dispense, prescribe, refer or recommend MMJ 2. Have no
More informationThe Cannabis Legal Landscape Today. Erika Lietzan University of Missouri School of Law November 2018
The Cannabis Legal Landscape Today Erika Lietzan University of Missouri School of November 2018 Federal CSA Int l State Federal FDCA Controlled Substances Act Schedule I: marihuana and tetrahydrocannabinols
More informationExtraction News Notes Blog
Extraction News Notes Blog www.infinitysupercritical.com BY: Infinity Supercritical Staff EG TAGS: Supercritical CO2 Oil Extraction, Cannabis, Oil Concentrates Sustainable Production of Cannabinoids with
More informationTexas Bill to Deregulate Marijuana
Texas Bill to Deregulate Marijuana With almost half of the United States legalizing medical marijuana and recreational use legalized in four other states, Texas could be next in line to deregulate the
More informationMarijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US
Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest
More informationCannabis Testing Laboratory Solutions
Cannabis Testing Laboratory Solutions We are the cannabis testing instrument experts. When purchasing analytical equipment, it is important to know that you are not just buying an instrument but investing
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationMULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA
MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA Submission on the Public Health (Medicinal Cannabis Affordability) Bill 2017 Queensland Health, Communities, Disability Services and Domestic
More informationMedicinal Marijuana: The Canadian Journey
Medicinal Marijuana: The Canadian Journey Nady el-guebaly MD Professor & Head, Addiction Division, UofC Research Director, Alberta Gambling Research Institute Chief Examiner, ISAM Certification Disclosures:
More information( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1
( 19 ) United States THE LETTERATURA DE LA MO NA ANI US 20170360745A1 ( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / 0360745 A1 Blackmon et al. ( 43 ) Pub. Date : Dec. 21, 2017 ( 54 )
More informationDevelopment of gas and liquid chromatographic methods for the separation and quantification of 11 cannabinoids
Development of gas and liquid chromatographic methods for the separation and quantification of 11 cannabinoids This thesis is presented for the degree of Bachelor of Science Honours, School of Veterinary
More information3. Based on these principles, I propose a Misuse of Drugs Amendment Bill that will:
In Confidence Office of the Minister of Health Chair Cabinet Business Committee Medicinal cannabis: 100-Day Action Proposal 1. This paper seeks Cabinet policy approval for legislative changes that will
More informationLearning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages
Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD CECILIA HILLARD, PHD DEPARTMENT OF PHARMACOLOGY NEUROSCIENCE RESEARCH CENTER Disclosures Member of the Scientific Advisory Board
More information(B) A testing laboratory shall analyze a sample of at least one half of one percent of the
ACTION: Final DATE: 08/14/2017 9:26 AM 3796:4-2-04 Testing laboratory analysis requirements. (A) A testing laboratory shall analyze a sample of at least one half of one percent of the net weight of the
More informationCannabis Legalization Wins Big On Election Day
Cannabis Legalization Wins Big On Election Day Neither Measure Amends The States' Existing Medical Marijuana Laws Washington, DC, USA: Voters on Election Day expressed unprecedented support for removing
More informationNew potential therapeutic applications for certain phytocannabinoids revealed by pharmacological discoveries Roger Pertwee
New potential therapeutic applications for certain phytocannabinoids revealed by pharmacological discoveries Roger Pertwee UNIVERSITY OF ABERDEEN Cannabis - a unique source of phytocannabinoids (at least
More informationLife s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE
Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE With the legalization of recreational cannabis upon us in Canada, our conversation about cannabis use is changing. It s not
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationMedical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD
Medical Marihuana for Patients in the Lymphoma Setting Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymhoma Setting Disclosure: No endorsement or promotion of marihuana
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationI would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people
I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid
More informationA summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids
A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids Background paper commissioned by the EMCDDA for the report Medical use of cannabis and cannabinoids:
More informationIs the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young
The Facts Cannabis, commonly known as marijuana and by numerous other names, is a preparation of the cannabis plant intended for use as a psychoactive drug and now as medicine. Marijuana also refers to
More informationQuestionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction
Introduction This is one of five questionnaires that Member States are invited to complete ahead of the 40th WHO Expert Committee on Drug Dependence. This questionnaire will ask you about cannabis plant
More informationCannabis Use: Scope of the Issue
Three Areas of Focus How Changing Cannabis Policy Will Affect Your Practice Kevin P. Hill, MD, MHS Director, McLean Hospital Division of Alcohol and Drug Abuse Belmont, MA Assistant Professor of Psychiatry,
More informationGlobal Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018
Global Legal Cannabis Market: Size, Trends & Forecasts (2018-2022) September 2018 Global Legal Cannabis Market: Coverage Executive Summary and Scope Introduction/Market Overview Global Market Analysis
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationEffects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
1479..1494 BJP British Journal of Pharmacology DOI:10.1111/j.1476-5381.2010.01166.x www.brjpharmacol.org Themed Issue: Cannabinoids in Biology and Medicine, Part I RESEARCH PAPERbph_1166 Effects of cannabinoids
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program
More informationSUPER SNOUTS CBD150 & CBD300 OIL FOR DOGS & CATS
SUPER SNOUTS CBD150 & CBD300 OIL FOR DOGS & CATS Why choose Super Snouts CBD Oils? Super Snouts has an outstanding reputation for creating well researched, effective and affordable health supplements for
More informationINFUSED II LABORATORY REPORT
1 of 1 879 Federal Blvd Denver, CO 80204 (303) 427-2379 License Number: 405-00008 405R-00011 INFUSED II LABORATORY REPORT Customer Name: Customer License: Batch Number: METRC Tag: Instrument Name: Triple
More informationDr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)
More informationSECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)
Regardless of a student, employee, parent or any individual s status as a medical marijuana license holder, marijuana is not allowed on the premises of the district or in any school vehicle or in any personal
More informationCANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY
CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY NOEL ROBERT WILLIAMS MD FACOG DIRECTOR OPTIMAL HEALTH ASSOCIATES OKLAHOMA CITY, OKLAHOMA How Did We Get Here? In November 2012 Tikun Olam,
More information420 ADVISORY MANAGEMENT
THE CANNABIS ACT: WHAT DOES IT MEAN FOR CANADIANS? 420 CLINIC, LTD. OBJECTIVES At the end of the session, you will be able to: 1) Understand the ramifications of recreational cannabis legalization 2) Understand
More informationCertificate of Analysis: Hemp Oil Liquid Emulsion-CE Product Name Hemp Oil Liquid Emulsion-CE Product Code BATCH LE17167 Date of Manufacture 28 July 2017 Botanical Source Industrial Hemp, grown and processed
More information